Angiopoietin-like 4

Angiopoietin-like 4 Informations sur la molécule

Nom anglais	Angiopoietin-related protein 4	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	3	Alias de la cible	Angiopoietin-like protein 4，Hepatic fibrinogen/angiopoietin-related protein，HFARP，ARP4，PGAR，PP1158，PSEC0166，UNQ171/PRO197，Angiopoietin Like 4，Hepatic Fibrinogen/Angiopoietin-Related Protein，Angiopoietin-Related Protein 4，Pp1158，FIAF，NL2，Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Induced Angiopoietin-Related Protein，Hepatic Angiopoietin-Related Protein，PPARG Angiopoietin Related Protein，Fasting-Induced Adipose Factor，Angiopoietin-Like Protein 4，Angiopoietin-Like 4，UNQ171，TGQTL，HARP
Phase de R&D la plus avancée	Phase 2 Clinical

Nom anglais	Angiopoietin-related protein 4
Alias de la cible	Angiopoietin-like protein 4，Hepatic fibrinogen/angiopoietin-related protein，HFARP，ARP4，PGAR，PP1158，PSEC0166，UNQ171/PRO197，Angiopoietin Like 4，Hepatic Fibrinogen/Angiopoietin-Related Protein，Angiopoietin-Related Protein 4，Pp1158，FIAF，NL2，Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Induced Angiopoietin-Related Protein，Hepatic Angiopoietin-Related Protein，PPARG Angiopoietin Related Protein，Fasting-Induced Adipose Factor，Angiopoietin-Like Protein 4，Angiopoietin-Like 4，UNQ171，TGQTL，HARP
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	3
Phase de R&D la plus avancée	Phase 2 Clinical

Angiopoietin-like 4 Liste de produits

Attribut
Protein (1)
Bibliothèque de produits
En ligne (1)
Espèces
Human (1)
Étiquette
His Tag (1)
Marqueur
Unconjugated (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
AN4-H5243	Human	HEK293	Human Angiopoietin-like 4 / ANGPTL4 (166-406) Protein, His Tag				Ajouter au panier

Quantité totale1

Angiopoietin-like 4Contexte de la molécule

Angiopoietin-related protein 4 (ANGPTL4) is also known as Hepatic fibrinogen / angiopoietin - related protein (HFARP), ARP4, PGAR. ANGPTL4 contains one fibrinogen C-terminal domain. ANGPTL4 is a homooligomer , and the homooligomer undergoes proteolytic processing to release its carboxyl fibrinogen-like domain, which circulates as a monomer. The homooligomer unprocessed form is able to interact with the extracellular matrix. ANGPTL4 may act as a regulator of angiogenesis and modulate tumorigenesis. ANGPTL4 inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. ANGPTL4 may exert a protective function on endothelial cells through an endocrine action.

Angiopoietin-like 4Alias de la molécule

ANGPTL4,ARP4,FIAF,HFARP,PGAR,pp1158,Angiopoietin like 4

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
MAR001	MAR001; MAR-001	Phase 2 Clinical	Mareas Therapeutic Services Inc	Hypertriglyceridemia	Details
Lipisense		Phase 1 Clinical	Lipigon Pharmaceuticals AB, Secarna Pharmaceuticals GmbH & Co KG	Hypertriglyceridemia	Details
A24110He	A24110He; A-24110-He	Phase 1 Clinical	Lipigon Pharmaceuticals AB	Hyperlipidemias; Hypertriglyceridemia	Details